Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 42 entries
Sorted by: Best Match Show Resources per page
LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent.

Oncoimmunology

Camilio KA, Rekdal O, Sveinbjörnsson B.
PMID: 25083333
Oncoimmunology. 2014 Jun 25;3:e29181. doi: 10.4161/onci.29181. eCollection 2014.

Several cationic antimicrobial peptides demonstrate promising anticancer effects. We have recently described the anticancer properties of LTX-315, a novel synthetic anticancer peptide, against syngeneic B16 melanomas. LTX-315 induced a complete regression of B16 melanomas and systemic protective immune responses...

Cite
Camilio KA, Rekdal O, Sveinbjörnsson B. LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent. Oncoimmunology. 2014;3:e29181doi: 10.4161/onci.29181.
Camilio, K. A., Rekdal, O., & Sveinbjörnsson, B. (2014). LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent. Oncoimmunology, 3e29181. https://doi.org/10.4161/onci.29181
Camilio, Ketil André, et al. "LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent." Oncoimmunology vol. 3 (2014): e29181. doi: https://doi.org/10.4161/onci.29181
Camilio KA, Rekdal O, Sveinbjörnsson B. LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent. Oncoimmunology. 2014 Jun 25;3:e29181. doi: 10.4161/onci.29181. eCollection 2014. PMID: 25083333; PMCID: PMC4108458.
Copy Download .nbib Format: NLM
Intrusion triggering of the 2010 Eyjafjallajökull explosive eruption.

Nature

Sigmundsson F, Hreinsdóttir S, Hooper A, Arnadóttir T, Pedersen R, Roberts MJ, Oskarsson N, Auriac A, Decriem J, Einarsson P, Geirsson H, Hensch M, Ofeigsson BG, Sturkell E, Sveinbjörnsson H, Feigl KL.
PMID: 21085177
Nature. 2010 Nov 18;468(7322):426-30. doi: 10.1038/nature09558.

Gradual inflation of magma chambers often precedes eruptions at highly active volcanoes. During such eruptions, rapid deflation occurs as magma flows out and pressure is reduced. Less is known about the deformation style at moderately active volcanoes, such as...

Cite
Sigmundsson F, Hreinsdóttir S, Hooper A, et al. Intrusion triggering of the 2010 Eyjafjallajökull explosive eruption. Nature. 2010;468(7322):426-30doi: 10.1038/nature09558.
Sigmundsson, F., Hreinsdóttir, S., Hooper, A., Arnadóttir, T., Pedersen, R., Roberts, M. J., Oskarsson, N., Auriac, A., Decriem, J., Einarsson, P., Geirsson, H., Hensch, M., Ofeigsson, B. G., Sturkell, E., Sveinbjörnsson, H., & Feigl, K. L. (2010). Intrusion triggering of the 2010 Eyjafjallajökull explosive eruption. Nature, 468(7322), 426-30. https://doi.org/10.1038/nature09558
Sigmundsson, Freysteinn, et al. "Intrusion triggering of the 2010 Eyjafjallajökull explosive eruption." Nature vol. 468,7322 (2010): 426-30. doi: https://doi.org/10.1038/nature09558
Sigmundsson F, Hreinsdóttir S, Hooper A, Arnadóttir T, Pedersen R, Roberts MJ, Oskarsson N, Auriac A, Decriem J, Einarsson P, Geirsson H, Hensch M, Ofeigsson BG, Sturkell E, Sveinbjörnsson H, Feigl KL. Intrusion triggering of the 2010 Eyjafjallajökull explosive eruption. Nature. 2010 Nov 18;468(7322):426-30. doi: 10.1038/nature09558. PMID: 21085177.
Copy Download .nbib Format: NLM
Improvement of a cytokine (TNF-α) bioassay by serum-free target cell (WEHI 164) cultivation.

Cytotechnology

Figenschau Y, Sveinbjörnsson B, Bertheussen K.
PMID: 22359061
Cytotechnology. 1999 Mar;29(2):121-34. doi: 10.1023/A:1008052307547.

The elaboration of a sensitive bioassay for assessment of tumour necrosis factor alpha (TNF-α) in a defined medium is described. The assay is based on the cytotoxic effect of TNF-α on a target cell line, the murine fibrosarcoma WEHI...

Cite
Figenschau Y, Sveinbjörnsson B, Bertheussen K. Improvement of a cytokine (TNF-α) bioassay by serum-free target cell (WEHI 164) cultivation. Cytotechnology. 1999;29(2):121-34doi: 10.1023/A:1008052307547.
Figenschau, Y., Sveinbjörnsson, B., & Bertheussen, K. (1999). Improvement of a cytokine (TNF-α) bioassay by serum-free target cell (WEHI 164) cultivation. Cytotechnology, 29(2), 121-34. https://doi.org/10.1023/A:1008052307547
Figenschau, Y, et al. "Improvement of a cytokine (TNF-α) bioassay by serum-free target cell (WEHI 164) cultivation." Cytotechnology vol. 29,2 (1999): 121-34. doi: https://doi.org/10.1023/A:1008052307547
Figenschau Y, Sveinbjörnsson B, Bertheussen K. Improvement of a cytokine (TNF-α) bioassay by serum-free target cell (WEHI 164) cultivation. Cytotechnology. 1999 Mar;29(2):121-34. doi: 10.1023/A:1008052307547. PMID: 22359061; PMCID: PMC3449908.
Copy Download .nbib Format: NLM
The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation.

Genes

Moens U, Kostenko S, Sveinbjørnsson B.
PMID: 24705157
Genes (Basel). 2013 Mar 26;4(2):101-33. doi: 10.3390/genes4020101.

Mitogen-activated protein kinase (MAPK) pathways are implicated in several cellular processes including proliferation, differentiation, apoptosis, cell survival, cell motility, metabolism, stress response and inflammation. MAPK pathways transmit and convert a plethora of extracellular signals by three consecutive phosphorylation events...

Cite
Moens U, Kostenko S, Sveinbjørnsson B. The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation. Genes (Basel). 2013;4(2):101-33doi: 10.3390/genes4020101.
Moens, U., Kostenko, S., & Sveinbjørnsson, B. (2013). The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation. Genes, 4(2), 101-33. https://doi.org/10.3390/genes4020101
Moens, Ugo, et al. "The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation." Genes vol. 4,2 (2013): 101-33. doi: https://doi.org/10.3390/genes4020101
Moens U, Kostenko S, Sveinbjørnsson B. The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation. Genes (Basel). 2013 Mar 26;4(2):101-33. doi: 10.3390/genes4020101. PMID: 24705157; PMCID: PMC3899974.
Copy Download .nbib Format: NLM
The genomics of heart failure: design and rationale of the HERMES consortium.

ESC heart failure

Lumbers RT, Shah S, Lin H, Czuba T, Henry A, Swerdlow DI, Mälarstig A, Andersson C, Verweij N, Holmes MV, Ärnlöv J, Svensson P, Hemingway H, Sallah N, Almgren P, Aragam KG, Asselin G, Backman JD, Biggs ML, Bloom HL, Boersma E, Brandimarto J, Brown MR, Brunner-La Rocca HP, Carey DJ, Chaffin MD, Chasman DI, Chazara O, Chen X, Chen X, Chung JH, Chutkow W, Cleland JGF, Cook JP, de Denus S, Dehghan A, Delgado GE, Denaxas S, Doney AS, Dörr M, Dudley SC, Engström G, Esko T, Fatemifar G, Felix SB, Finan C, Ford I, Fougerousse F, Fouodjio R, Ghanbari M, Ghasemi S, Giedraitis V, Giulianini F, Gottdiener JS, Gross S, Guðbjartsson DF, Gui H, Gutmann R, Haggerty CM, van der Harst P, Hedman ÅK, Helgadottir A, Hillege H, Hyde CL, Jacob J, Jukema JW, Kamanu F, Kardys I, Kavousi M, Khaw KT, Kleber ME, Køber L, Koekemoer A, Kraus B, Kuchenbaecker K, Langenberg C, Lind L, Lindgren CM, London B, Lotta LA, Lovering RC, Luan J, Magnusson P, Mahajan A, Mann D, Margulies KB, Marston NA, März W, McMurray JJV, Melander O, Melloni G, Mordi IR, Morley MP, Morris AD, Morris AP, Morrison AC, Nagle MW, Nelson CP, Newton-Cheh C, Niessner A, Niiranen T, Nowak C, O'Donoghue ML, Owens AT, Palmer CNA, Paré G, Perola M, Perreault LL, Portilla-Fernandez E, Psaty BM, Rice KM, Ridker PM, Romaine SPR, Roselli C, Rotter JI, Ruff CT, Sabatine MS, Salo P, Salomaa V, van Setten J, Shalaby AA, Smelser DT, Smith NL, Stefansson K, Stender S, Stott DJ, Sveinbjörnsson G, Tammesoo ML, Tardif JC, Taylor KD, Teder-Laving M, Teumer A, Thorgeirsson G, Thorsteinsdottir U, Torp-Pedersen C, Trompet S, Tuckwell D, Tyl B, Uitterlinden AG, Vaura F, Veluchamy A, Visscher PM, Völker U, Voors AA, Wang X, Wareham NJ, Weeke PE, Weiss R, White HD, Wiggins KL, Xing H, Yang J, Yang Y, Yerges-Armstrong LM, Yu B, Zannad F, Zhao F, Wilk JB, Holm H, Sattar N, Lubitz SA, Lanfear DE, Shah S, Dunn ME, Wells QS, Asselbergs FW, Hingorani AD, Dubé MP, Samani NJ, Lang CC, Cappola TP, Ellinor PT, Vasan RS, Smith JG.
PMID: 34480422
ESC Heart Fail. 2021 Sep 03; doi: 10.1002/ehf2.13517. Epub 2021 Sep 03.

AIMS: The HERMES (HEart failure Molecular Epidemiology for Therapeutic targetS) consortium aims to identify the genomic and molecular basis of heart failure.METHODS AND RESULTS: The consortium currently includes 51 studies from 11 countries, including 68 157 heart failure cases...

Cite
Lumbers RT, Shah S, Lin H, et al. The genomics of heart failure: design and rationale of the HERMES consortium. ESC Heart Fail. 2021;doi: 10.1002/ehf2.13517.
Lumbers, R. T., Shah, S., Lin, H., Czuba, T., Henry, A., Swerdlow, D. I., Mälarstig, A., Andersson, C., Verweij, N., Holmes, M. V., Ärnlöv, J., Svensson, P., Hemingway, H., Sallah, N., Almgren, P., Aragam, K. G., Asselin, G., Backman, J. D., Biggs, M. L., Bloom, H. L., Boersma, E., Brandimarto, J., Brown, M. R., Brunner-La Rocca, H. P., Carey, D. J., Chaffin, M. D., Chasman, D. I., Chazara, O., Chen, X., Chen, X., Chung, J. H., Chutkow, W., Cleland, J. G. F., Cook, J. P., de Denus, S., Dehghan, A., Delgado, G. E., Denaxas, S., Doney, A. S., Dörr, M., Dudley, S. C., Engström, G., Esko, T., Fatemifar, G., Felix, S. B., Finan, C., Ford, I., Fougerousse, F., Fouodjio, R., Ghanbari, M., Ghasemi, S., Giedraitis, V., Giulianini, F., Gottdiener, J. S., Gross, S., Guðbjartsson, D. F., Gui, H., Gutmann, R., Haggerty, C. M., van der Harst, P., Hedman, �. �. K., Helgadottir, A., Hillege, H., Hyde, C. L., Jacob, J., Jukema, J. W., Kamanu, F., Kardys, I., Kavousi, M., Khaw, K. T., Kleber, M. E., Køber, L., Koekemoer, A., Kraus, B., Kuchenbaecker, K., Langenberg, C., Lind, L., Lindgren, C. M., London, B., Lotta, L. A., Lovering, R. C., Luan, J., Magnusson, P., Mahajan, A., Mann, D., Margulies, K. B., Marston, N. A., März, W., McMurray, J. J. V., Melander, O., Melloni, G., Mordi, I. R., Morley, M. P., Morris, A. D., Morris, A. P., Morrison, A. C., Nagle, M. W., Nelson, C. P., Newton-Cheh, C., Niessner, A., Niiranen, T., Nowak, C., O'Donoghue, M. L., Owens, A. T., Palmer, C. N. A., Paré, G., Perola, M., Perreault, L. L., Portilla-Fernandez, E., Psaty, B. M., Rice, K. M., Ridker, P. M., Romaine, S. P. R., Roselli, C., Rotter, J. I., Ruff, C. T., Sabatine, M. S., Salo, P., Salomaa, V., van Setten, J., Shalaby, A. A., Smelser, D. T., Smith, N. L., Stefansson, K., Stender, S., Stott, D. J., Sveinbjörnsson, G., Tammesoo, M. L., Tardif, J. C., Taylor, K. D., Teder-Laving, M., Teumer, A., Thorgeirsson, G., Thorsteinsdottir, U., Torp-Pedersen, C., Trompet, S., Tuckwell, D., Tyl, B., Uitterlinden, A. G., Vaura, F., Veluchamy, A., Visscher, P. M., Völker, U., Voors, A. A., Wang, X., Wareham, N. J., Weeke, P. E., Weiss, R., White, H. D., Wiggins, K. L., Xing, H., Yang, J., Yang, Y., Yerges-Armstrong, L. M., Yu, B., Zannad, F., Zhao, F., Wilk, J. B., Holm, H., Sattar, N., Lubitz, S. A., Lanfear, D. E., Shah, S., Dunn, M. E., Wells, Q. S., Asselbergs, F. W., Hingorani, A. D., Dubé, M. P., Samani, N. J., Lang, C. C., Cappola, T. P., Ellinor, P. T., Vasan, R. S., & Smith, J. G. (2021). The genomics of heart failure: design and rationale of the HERMES consortium. ESC heart failure, . https://doi.org/10.1002/ehf2.13517
Lumbers, R Thomas, et al. "The genomics of heart failure: design and rationale of the HERMES consortium." ESC heart failure vol. (2021). doi: https://doi.org/10.1002/ehf2.13517
Lumbers RT, Shah S, Lin H, Czuba T, Henry A, Swerdlow DI, Mälarstig A, Andersson C, Verweij N, Holmes MV, Ärnlöv J, Svensson P, Hemingway H, Sallah N, Almgren P, Aragam KG, Asselin G, Backman JD, Biggs ML, Bloom HL, Boersma E, Brandimarto J, Brown MR, Brunner-La Rocca HP, Carey DJ, Chaffin MD, Chasman DI, Chazara O, Chen X, Chen X, Chung JH, Chutkow W, Cleland JGF, Cook JP, de Denus S, Dehghan A, Delgado GE, Denaxas S, Doney AS, Dörr M, Dudley SC, Engström G, Esko T, Fatemifar G, Felix SB, Finan C, Ford I, Fougerousse F, Fouodjio R, Ghanbari M, Ghasemi S, Giedraitis V, Giulianini F, Gottdiener JS, Gross S, Guðbjartsson DF, Gui H, Gutmann R, Haggerty CM, van der Harst P, Hedman ÅK, Helgadottir A, Hillege H, Hyde CL, Jacob J, Jukema JW, Kamanu F, Kardys I, Kavousi M, Khaw KT, Kleber ME, Køber L, Koekemoer A, Kraus B, Kuchenbaecker K, Langenberg C, Lind L, Lindgren CM, London B, Lotta LA, Lovering RC, Luan J, Magnusson P, Mahajan A, Mann D, Margulies KB, Marston NA, März W, McMurray JJV, Melander O, Melloni G, Mordi IR, Morley MP, Morris AD, Morris AP, Morrison AC, Nagle MW, Nelson CP, Newton-Cheh C, Niessner A, Niiranen T, Nowak C, O'Donoghue ML, Owens AT, Palmer CNA, Paré G, Perola M, Perreault LL, Portilla-Fernandez E, Psaty BM, Rice KM, Ridker PM, Romaine SPR, Roselli C, Rotter JI, Ruff CT, Sabatine MS, Salo P, Salomaa V, van Setten J, Shalaby AA, Smelser DT, Smith NL, Stefansson K, Stender S, Stott DJ, Sveinbjörnsson G, Tammesoo ML, Tardif JC, Taylor KD, Teder-Laving M, Teumer A, Thorgeirsson G, Thorsteinsdottir U, Torp-Pedersen C, Trompet S, Tuckwell D, Tyl B, Uitterlinden AG, Vaura F, Veluchamy A, Visscher PM, Völker U, Voors AA, Wang X, Wareham NJ, Weeke PE, Weiss R, White HD, Wiggins KL, Xing H, Yang J, Yang Y, Yerges-Armstrong LM, Yu B, Zannad F, Zhao F, Wilk JB, Holm H, Sattar N, Lubitz SA, Lanfear DE, Shah S, Dunn ME, Wells QS, Asselbergs FW, Hingorani AD, Dubé MP, Samani NJ, Lang CC, Cappola TP, Ellinor PT, Vasan RS, Smith JG. The genomics of heart failure: design and rationale of the HERMES consortium. ESC Heart Fail. 2021 Sep 03; doi: 10.1002/ehf2.13517. Epub 2021 Sep 03. PMID: 34480422.
Copy Download .nbib Format: NLM
Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions.

ACS omega

Ghasemisarabbadieh M, Gizurarson S, Sveinbjornsson BR.
PMID: 33681619
ACS Omega. 2021 Feb 15;6(8):5805-5811. doi: 10.1021/acsomega.0c06248. eCollection 2021 Mar 02.

In this study, the effect of 18-crown-6 on the stability of oxytocin in aqueous solution was explored. The study found that while 12-crown-4 and 15-crown-5 do not stabilize oxytocin, 18-crown-6 does have a stabilizing effect in citrate/phosphate buffer at...

Cite
Ghasemisarabbadieh M, Gizurarson S, Sveinbjornsson BR. Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions. ACS Omega. 2021;6(8):5805-5811doi: 10.1021/acsomega.0c06248.
Ghasemisarabbadieh, M., Gizurarson, S., & Sveinbjornsson, B. R. (2021). Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions. ACS omega, 6(8), 5805-5811. https://doi.org/10.1021/acsomega.0c06248
Ghasemisarabbadieh, Mostafa, et al. "Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions." ACS omega vol. 6,8 (2021): 5805-5811. doi: https://doi.org/10.1021/acsomega.0c06248
Ghasemisarabbadieh M, Gizurarson S, Sveinbjornsson BR. Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions. ACS Omega. 2021 Feb 15;6(8):5805-5811. doi: 10.1021/acsomega.0c06248. eCollection 2021 Mar 02. PMID: 33681619; PMCID: PMC7931373.
Copy Download .nbib Format: NLM
Large-scale integration of the plasma proteome with genetics and disease.

Nature genetics

Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV, Jensson BO, Zink F, Halldorsson GH, Masson G, Arnadottir GA, Katrinardottir H, Juliusson K, Magnusson MK, Magnusson OT, Fridriksdottir R, Saevarsdottir S, Gudjonsson SA, Stacey SN, Rognvaldsson S, Eiriksdottir T, Olafsdottir TA, Steinthorsdottir V, Tragante V, Ulfarsson MO, Stefansson H, Jonsdottir I, Holm H, Rafnar T, Melsted P, Saemundsdottir J, Norddahl GL, Lund SH, Gudbjartsson DF, Thorsteinsdottir U, Stefansson K.
PMID: 34857953
Nat Genet. 2021 Dec;53(12):1712-1721. doi: 10.1038/s41588-021-00978-w. Epub 2021 Dec 02.

The plasma proteome can help bridge the gap between the genome and diseases. Here we describe genome-wide association studies (GWASs) of plasma protein levels measured with 4,907 aptamers in 35,559 Icelanders. We found 18,084 associations between sequence variants and...

Cite
Ferkingstad E, Sulem P, Atlason BA, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712-1721doi: 10.1038/s41588-021-00978-w.
Ferkingstad, E., Sulem, P., Atlason, B. A., Sveinbjornsson, G., Magnusson, M. I., Styrmisdottir, E. L., Gunnarsdottir, K., Helgason, A., Oddsson, A., Halldorsson, B. V., Jensson, B. O., Zink, F., Halldorsson, G. H., Masson, G., Arnadottir, G. A., Katrinardottir, H., Juliusson, K., Magnusson, M. K., Magnusson, O. T., Fridriksdottir, R., Saevarsdottir, S., Gudjonsson, S. A., Stacey, S. N., Rognvaldsson, S., Eiriksdottir, T., Olafsdottir, T. A., Steinthorsdottir, V., Tragante, V., Ulfarsson, M. O., Stefansson, H., Jonsdottir, I., Holm, H., Rafnar, T., Melsted, P., Saemundsdottir, J., Norddahl, G. L., Lund, S. H., Gudbjartsson, D. F., Thorsteinsdottir, U., & Stefansson, K. (2021). Large-scale integration of the plasma proteome with genetics and disease. Nature genetics, 53(12), 1712-1721. https://doi.org/10.1038/s41588-021-00978-w
Ferkingstad, Egil, et al. "Large-scale integration of the plasma proteome with genetics and disease." Nature genetics vol. 53,12 (2021): 1712-1721. doi: https://doi.org/10.1038/s41588-021-00978-w
Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, Gunnarsdottir K, Helgason A, Oddsson A, Halldorsson BV, Jensson BO, Zink F, Halldorsson GH, Masson G, Arnadottir GA, Katrinardottir H, Juliusson K, Magnusson MK, Magnusson OT, Fridriksdottir R, Saevarsdottir S, Gudjonsson SA, Stacey SN, Rognvaldsson S, Eiriksdottir T, Olafsdottir TA, Steinthorsdottir V, Tragante V, Ulfarsson MO, Stefansson H, Jonsdottir I, Holm H, Rafnar T, Melsted P, Saemundsdottir J, Norddahl GL, Lund SH, Gudbjartsson DF, Thorsteinsdottir U, Stefansson K. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021 Dec;53(12):1712-1721. doi: 10.1038/s41588-021-00978-w. Epub 2021 Dec 02. PMID: 34857953.
Copy Download .nbib Format: NLM
LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects.

Cell stress

Liao HW, Garris C, Pfirschke C, Rickelt S, Arlauckas S, Siwicki M, Kohler RH, Weissleder R, Sundvold-Gjerstad V, Sveinbjørnsson B, Rekdal Ø, Pittet MJ.
PMID: 31799501
Cell Stress. 2019 Oct 14;3(11):348-360. doi: 10.15698/cst2019.11.204.

LTX-315 is an oncolytic peptide that has antitumor efficacy in mice grafted with various tumor cell lines and is currently being tested in phase II clinical trials. Here we aimed to further evaluate LTX-315 in conditional genetic mouse models...

Cite
Liao HW, Garris C, Pfirschke C, et al. LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects. Cell Stress. 2019;3(11):348-360doi: 10.15698/cst2019.11.204.
Liao, H. W., Garris, C., Pfirschke, C., Rickelt, S., Arlauckas, S., Siwicki, M., Kohler, R. H., Weissleder, R., Sundvold-Gjerstad, V., Sveinbjørnsson, B., Rekdal, �. �., & Pittet, M. J. (2019). LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects. Cell stress, 3(11), 348-360. https://doi.org/10.15698/cst2019.11.204
Liao, Hsin-Wei, et al. "LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects." Cell stress vol. 3,11 (2019): 348-360. doi: https://doi.org/10.15698/cst2019.11.204
Liao HW, Garris C, Pfirschke C, Rickelt S, Arlauckas S, Siwicki M, Kohler RH, Weissleder R, Sundvold-Gjerstad V, Sveinbjørnsson B, Rekdal Ø, Pittet MJ. LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects. Cell Stress. 2019 Oct 14;3(11):348-360. doi: 10.15698/cst2019.11.204. PMID: 31799501; PMCID: PMC6859426.
Copy Download .nbib Format: NLM
Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability .

Oncotarget

Tümmler C, Snapkov I, Wickström M, Moens U, Ljungblad L, Maria Elfman LH, Winberg JO, Kogner P, Johnsen JI, Sveinbjørnsson B.
PMID: 29221117
Oncotarget. 2017 Jul 27;8(56):95135-95151. doi: 10.18632/oncotarget.19619. eCollection 2017 Nov 10.

Pro-inflammatory cells, cytokines, and chemokines are essential in promoting a tumor supporting microenvironment. Chemerin is a chemotactic protein and a natural ligand for the receptors CMKLR1, GPR1, and CCRL2. The chemerin/CMKLR1 axis is involved in immunity and inflammation, and...

Cite
Tümmler C, Snapkov I, Wickström M, et al. Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability . Oncotarget. 2017;8(56):95135-95151doi: 10.18632/oncotarget.19619.
Tümmler, C., Snapkov, I., Wickström, M., Moens, U., Ljungblad, L., Maria Elfman, L. H., Winberg, J. O., Kogner, P., Johnsen, J. I., & Sveinbjørnsson, B. (2017). Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability . Oncotarget, 8(56), 95135-95151. https://doi.org/10.18632/oncotarget.19619
Tümmler, Conny, et al. "Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability ." Oncotarget vol. 8,56 (2017): 95135-95151. doi: https://doi.org/10.18632/oncotarget.19619
Tümmler C, Snapkov I, Wickström M, Moens U, Ljungblad L, Maria Elfman LH, Winberg JO, Kogner P, Johnsen JI, Sveinbjørnsson B. Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability . Oncotarget. 2017 Jul 27;8(56):95135-95151. doi: 10.18632/oncotarget.19619. eCollection 2017 Nov 10. PMID: 29221117; PMCID: PMC5707011.
Copy Download .nbib Format: NLM
CCL17/TARC and CCR4 expression in Merkel cell carcinoma.

Oncotarget

Rasheed K, Abdulsalam I, Fismen S, Grimstad Ø, Sveinbjørnsson B, Moens U.
PMID: 30140381
Oncotarget. 2018 Jul 31;9(59):31432-31447. doi: 10.18632/oncotarget.25836. eCollection 2018 Jul 31.

Merkel cell carcinoma (MCC) is a rare, highly aggressive neuroendocrine skin cancer. In more than 80% of the cases, Merkel cell polyomavirus (MCPyV) is a causal factor. The oncogenic potential of MCPyV is mediated through its viral oncoproteins, large...

Cite
Rasheed K, Abdulsalam I, Fismen S, et al. CCL17/TARC and CCR4 expression in Merkel cell carcinoma. Oncotarget. 2018;9(59):31432-31447doi: 10.18632/oncotarget.25836.
Rasheed, K., Abdulsalam, I., Fismen, S., Grimstad, �. �., Sveinbjørnsson, B., & Moens, U. (2018). CCL17/TARC and CCR4 expression in Merkel cell carcinoma. Oncotarget, 9(59), 31432-31447. https://doi.org/10.18632/oncotarget.25836
Rasheed, Kashif, et al. "CCL17/TARC and CCR4 expression in Merkel cell carcinoma." Oncotarget vol. 9,59 (2018): 31432-31447. doi: https://doi.org/10.18632/oncotarget.25836
Rasheed K, Abdulsalam I, Fismen S, Grimstad Ø, Sveinbjørnsson B, Moens U. CCL17/TARC and CCR4 expression in Merkel cell carcinoma. Oncotarget. 2018 Jul 31;9(59):31432-31447. doi: 10.18632/oncotarget.25836. eCollection 2018 Jul 31. PMID: 30140381; PMCID: PMC6101144.
Copy Download .nbib Format: NLM
The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes.

Oncoimmunology

Carlson LM, De Geer A, Sveinbjørnsson B, Orrego A, Martinsson T, Kogner P, Levitskaya J.
PMID: 23802089
Oncoimmunology. 2013 Mar 01;2(3):e23618. doi: 10.4161/onci.23618.

Tumor infiltration by lymphocytes has been linked to improved clinical outcome in children with neuroblastoma (NB) but T-cell activation has never been demonstrated to occur within the NB microenvironment. Here we show that tumor-associated lymphocytes (TALs) obtained from lesions...

Cite
Carlson LM, De Geer A, Sveinbjørnsson B, et al. The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes. Oncoimmunology. 2013;2(3):e23618doi: 10.4161/onci.23618.
Carlson, L. M., De Geer, A., Sveinbjørnsson, B., Orrego, A., Martinsson, T., Kogner, P., & Levitskaya, J. (2013). The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes. Oncoimmunology, 2(3), e23618. https://doi.org/10.4161/onci.23618
Carlson, Lena-Maria, et al. "The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes." Oncoimmunology vol. 2,3 (2013): e23618. doi: https://doi.org/10.4161/onci.23618
Carlson LM, De Geer A, Sveinbjørnsson B, Orrego A, Martinsson T, Kogner P, Levitskaya J. The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes. Oncoimmunology. 2013 Mar 01;2(3):e23618. doi: 10.4161/onci.23618. PMID: 23802089; PMCID: PMC3661174.
Copy Download .nbib Format: NLM
Probing Photocurrent Generation, Charge Transport, and Recombination Mechanisms in Mesostructured Hybrid Perovskite through Photoconductivity Measurements.

The journal of physical chemistry letters

Sveinbjörnsson K, Aitola K, Zhang X, Pazoki M, Hagfeldt A, Boschloo G, Johansson EM.
PMID: 26538041
J Phys Chem Lett. 2015 Nov 05;6(21):4259-64. doi: 10.1021/acs.jpclett.5b02044. Epub 2015 Oct 13.

Conductivity of methylammonium lead triiodide (MAPbI3) perovskite was measured on different mesoporous metal oxide scaffolds: TiO2, Al2O3, and ZrO2, as a function of incident light irradiation and temperature. It was found that MAPbI3 exhibits intrinsic charge separation, and its...

Cite
Sveinbjörnsson K, Aitola K, Zhang X, et al. Probing Photocurrent Generation, Charge Transport, and Recombination Mechanisms in Mesostructured Hybrid Perovskite through Photoconductivity Measurements. J Phys Chem Lett. 2015;6(21):4259-64doi: 10.1021/acs.jpclett.5b02044.
Sveinbjörnsson, K., Aitola, K., Zhang, X., Pazoki, M., Hagfeldt, A., Boschloo, G., & Johansson, E. M. (2015). Probing Photocurrent Generation, Charge Transport, and Recombination Mechanisms in Mesostructured Hybrid Perovskite through Photoconductivity Measurements. The journal of physical chemistry letters, 6(21), 4259-64. https://doi.org/10.1021/acs.jpclett.5b02044
Sveinbjörnsson, Kári, et al. "Probing Photocurrent Generation, Charge Transport, and Recombination Mechanisms in Mesostructured Hybrid Perovskite through Photoconductivity Measurements." The journal of physical chemistry letters vol. 6,21 (2015): 4259-64. doi: https://doi.org/10.1021/acs.jpclett.5b02044
Sveinbjörnsson K, Aitola K, Zhang X, Pazoki M, Hagfeldt A, Boschloo G, Johansson EM. Probing Photocurrent Generation, Charge Transport, and Recombination Mechanisms in Mesostructured Hybrid Perovskite through Photoconductivity Measurements. J Phys Chem Lett. 2015 Nov 05;6(21):4259-64. doi: 10.1021/acs.jpclett.5b02044. Epub 2015 Oct 13. PMID: 26538041.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 42 entries